First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity
Clinical trial NCT03015207 · COMPLETED
Trial details
- NCT number
- NCT03015207
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-06
- Primary completion
- 2017-10-26
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.